Company: NDRA
Filing Date: 2025-11-06
Form Type: S-3
Source: 0001213900-25-107232
Chunk: 2

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-06
Form: S-3
Chunk 2
---
680 shares
(the “Shares”) of our common stock, par value $0.0001 per share (“common stock”), consisting of (i) 379,539 shares
of common stock (the “PIPE Shares”) issued pursuant to the securities purchase agreement, dated October 10, 2025 (the “Purchase
Agreement”), (ii) 364,801 shares of common stock underlying pre-funded warrants issued pursuant to the Purchase Agreement (the
“Pre-Funded Warrant Shares” and such warrants, the “Pre-Funded Warrants”), (iii) 1,488,680 shares of common stock
underlying warrants issued pursuant to the Purchase Agreement (the “Common Warrant Shares” and such warrants, the “Common
Warrants”), (iv) 400,000 shares of common stock underlying warrants issued to Arca Investment Management, LLC (the “Arca
Warrant Shares” and such warrants, the “Arca Warrants”) and (v) 44,660 shares of common stock underlying warrants issued
to designees of Lucid Capital Markets LLC (the “Placement Agent Warrant Shares” and such warrants, the “Placement
Agent Warrants”). The Pre-Funded Warrants, Common Warrants, Arca Warrants and Placement Agent Warrants are collectively referred
to as the “Warrants.” The PIPE Shares and the Warrant Shares are collectively referred to as the “Shares.” The
Pre-Funded Warrant Shares, Common Warrant Shares, Arca Warrant Shares and Placement Agent Warrant Shares are collectively referred to
as the “Warrant Shares.”

Our registration of the securities
covered by this prospectus does not mean that the selling stockholders will sell any of the Shares or exercise any of the Warrants. We
are not offering for sale any shares of our common stock pursuant to this prospectus. The selling stockholders may sell or otherwise
dispose of the Shares publicly or through private transactions at prevailing market prices or at negotiated prices. We provide more information
about how the selling stockholders may sell their Shares in the section entitled “Plan of Distribution.”

We will bear all costs, expenses
and fees in connection with the registration of the Shares. The selling stockholders will bear all commissions and discounts, if any,
attributable to their respective sales of the Shares. For more information about the selling stockholders, please see the section entitled
“Selling Stockholders.”

We will not receive any proceeds
from the sale of Shares by the selling stockholders